Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:0874)

HKG:0874 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	44,169	46,522	49,079	52,405	63,956	53,019
Market Cap Growth	-0.09%	-5.21%	-6.35%	-18.06%	20.63%	-14.28%
Enterprise Value	43,993	44,784	42,540	43,385	50,299	43,000
Last Close Price	19.20	17.34	19.49	19.94	18.77	15.42
PE Ratio	13.53	15.42	10.99	11.69	14.01	15.31
PS Ratio	0.52	0.58	0.59	0.66	0.76	0.72
PB Ratio	1.01	1.16	1.22	1.38	1.66	1.58
P/TBV Ratio	1.18	1.36	1.43	1.62	2.03	1.95
P/FCF Ratio	40.56	18.89	18.00	8.26	11.79	-
P/OCF Ratio	18.19	12.70	10.86	6.62	9.18	76.29
EV/Sales Ratio	0.50	0.56	0.51	0.54	0.59	0.59
EV/EBITDA Ratio	8.66	10.34	7.07	7.67	9.33	10.60
EV/EBIT Ratio	10.48	12.11	8.05	8.55	10.32	11.96
EV/FCF Ratio	40.40	18.18	15.60	6.84	9.27	-
Debt / Equity Ratio	0.40	0.37	0.33	0.36	0.32	0.34
Debt / EBITDA Ratio	3.59	3.23	2.09	2.30	2.14	2.60
Debt / FCF Ratio	16.16	6.01	4.83	2.14	2.25	-
Asset Turnover	0.96	0.94	0.99	1.01	1.10	1.06
Inventory Turnover	5.77	5.14	5.53	5.45	5.53	5.33
Quick Ratio	1.15	1.11	1.17	1.20	1.27	1.23
Current Ratio	1.60	1.48	1.55	1.53	1.64	1.62
Return on Equity (ROE)	7.97%	8.06%	12.12%	13.09%	13.33%	11.41%
Return on Assets (ROA)	2.85%	2.71%	3.91%	3.98%	3.94%	3.24%
Return on Invested Capital (ROIC)	8.39%	10.41%	16.80%	18.98%	17.98%	15.46%
Return on Capital Employed (ROCE)	8.20%	8.10%	11.30%	12.00%	11.70%	9.90%
Earnings Yield	7.39%	6.49%	9.10%	8.56%	7.14%	6.53%
FCF Yield	2.47%	5.29%	5.56%	12.11%	8.48%	-0.65%
Dividend Yield	4.56%	4.91%	4.23%	4.15%	4.49%	4.14%
Payout Ratio	77.85%	79.38%	39.09%	37.58%	34.03%	44.25%
Buyback Yield / Dilution	-0.01%	-0.02%	0.02%	-	-	-
Total Shareholder Return	4.55%	4.89%	4.25%	4.15%	4.49%	4.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.